Evaluation of investigational drugs

ILSE provides essential microbiological services necessary to accelerate the development of investigational drugs

We collaborate with clients to customize research projects and rapidly deliver high quality results regardless of the study size.

  • Microbial diagnostics
  • Antimicrobial compounds
  • Alternative antimicrobials
  • Infection prevention
  • Antimicrobial stewardship
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Fungi
  • Yeasts
  • Viruses
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

  • Institute
  • Company
  • Academia
  • NGO
  • Government

  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:

        Interesting scientific problems that ILSE can contribute to solving; flexible partnering models

        Research institute, business accelerator and incubator for microbiology, microbial genomics, bioinformatics, microbiome, clinical microbiology

        We provide molecular biology services, including generation of custom bacterial strains, microbiome analysis, in vitro cytotoxicity and biochemical assay screening, and extensive consulting experience in all phases of drug development.

        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!